| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8684033 | Epilepsy Research | 2018 | 4 Pages |
Abstract
These results of real-life setting show LCM to be efficacious and safe when used as first add-on therapy for focal-onset epilepsy. Most adverse events were mild and/or transient.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Amaia Muñoz-Lopetegi, Francisco Javier López-González, Xiana RodrÃguez-Osorio, Antonio Pato Pato, Paula Bellas Lamas, Javier Abella-Corral, MarÃa Dolores Castro Vilanova, MarÃa José Garea, Juan Antonio Gil López, Javier Ruiz-MartÃnez,